Diesel Fuel Shortage Sets Stage for Next Biden Created Crisis


Posted originally on the conservative tree house on May 12, 2022 | Sundance

It has often been said that if you chase the global climate change ideology to its natural conclusion, we end up in communal groups sitting around a tepid campfire eating some form of sustainable algae cakes and picking parasites off each other…  Prior to Joe Biden that prediction might have seemed like hyperbole. Now, not so much.

Indeed, the Green New Deal energy policy of Joe Biden creates massive downstream consequences.  Unfortunately, the White House doesn’t seem to care. The high prices and scarcity of critical goods are a feature, not a flaw, as they chase their climate friendly Build Back Better agenda.

Following the continuum of intended consequence, now we have diesel fuel shortages beginning to hit the U.S. economy; and with scarcity comes higher prices of an almost astronomical scale. “The national average price of diesel is now $5.54 per gallon, which is an increase of 22 cents from last week, which was when the most recent record was set. Data shows there’s no state that’s currently seeing diesel prices below $5.12 per gallon.” (LINK)

Making matters even worse is a drop in available inventory of diesel fuel which is about to become a crisis for the east coast of the U.S.  Some Truck Stop operators like Love’s and Pilot are already warning their big rig customers they may not have fuel for truckers.

[…] “Love’s is monitoring the fluid situation on the East Coast, we have experienced minimal outages during low traffic hours,” Oklahoma-based Love’s Travel Stops said in an emailed statement. “The company has no plans to restrict purchases of diesel.”

[…] Earlier on Wednesday, the U.S. government’s Energy Information Administration said total inventories of distillates, which is mainly diesel fuel but also heating oil, fell last week to a 17-year low of 104 million barrels, which is 23% below normal.

On the East Coast, the situation is even worse. The EIA said distillate fuel oil inventories in the so-called PADD 1 district that covers the Northeastern states fell by 1.1 million barrels last week to just 21 million barrels, the lowest ever recorded in data going back to 1990.

Love’s truck stops, with some 550 locations across 41 states, also seemed to confirm reports on social media Wednesday that said Love’s and other truck stops such as Pilot were informing their fleet operators that shortages of diesel fuel on the East Coast may happen in the coming week at some stores. (read more)

Not only is the logistics of transportation contingent upon the use of diesel fuel for tractor trailer deliveries of essential goods, the other big users of diesel fuel are also farmers.

If it wasn’t challenging enough to triple the price farmers are paying for fertilizer this year, now the costs to operate the equipment they depend on has just doubled with the increases in diesel fuel.

Some farmers are now even reporting farm diesel prices are higher than on-road diesel, which is typically not the case. … Certain areas of the country have seen shortages already and we expect that to continue. Supplies at New York Harbor–a hub for diesel distribution–are at a 30-year low,” says Meyer. “As such, the East Coast of the U.S. has been hit especially hard, resulting in diesel prices above $6.00 per gallon in that area.  (more)

ENERGY POLICY:

♦ West Coast ports that cannot handle container off-loads due to emission regulations.

♦ Nationwide fertilizer shortages and high prices.

♦ Massive increases in gasoline and diesel fuel costs.

♦ Limited shoreline refinery capacity due to federal regulations.

♦ Stunning increases in food costs at the grocery store.

… And what does the administration do against this backdrop?

WASHINGTON (AP) — The Biden administration says it is canceling three oil and gas lease sales scheduled in the Gulf of Mexico and off the coast of Alaska, removing millions of acres from possible drilling as U.S. gas prices reach record highs.

The Interior Department announced the decision Wednesday night, citing a lack of industry interest in drilling off the Alaska coast and “conflicting court rulings” that have complicated drilling efforts in the Gulf of Mexico, where the bulk of U.S. offshore drilling takes place.

The decision likely means the Biden administration will not hold a lease sale for offshore drilling this year and comes as Interior appears set to let a mandatory five-year plan for offshore drilling expire next month.

[…] A federal appeals court in New Orleans, meanwhile, is considering a challenge to a moratorium on new federal leasing that Biden imposed soon after taking office in January 2021. Biden said the administration needed to consider the effect of new drilling on climate change and conduct proper environmental reviews.

Louisiana and 12 other states challenged Biden’s order, saying laws passed in response to the 1970s oil crisis require lease sales on federal lands and waters.

The Biden administration failed to “grapple with prior analyses” of the planned sales to give a valid reason for postponing or canceling them, Louisiana Deputy Solicitor General Joseph Scott St. John told a 5th U.S. Circuit Court of Appeals panel this week.  The three-judge panel did not indicate when they will rule. (read more)

Brilliant Satire Contrasts National Priorities of Joe Biden


Posted originally on the conservative tree house on May 12, 2022 | Sundance

When the satire hits the central nerve of accuracy….

(READ HERE)

Airlines Playing Russian Roulette with Passengers’ Lives


Armstrong Economics Blog/Vaccine Re-Posted May 11, 2022 by Martin Armstrong

Airlines are playing Russian roulette with passengers’ lives after numerous pilots experienced heart attacks, which is believed to be a direct result of the vaccine mandate.

American Airlines Captain Robert Snow was flying an Airbus 231 carrying 200 passengers. An otherwise healthy Snow experienced a sudden heart attack six minutes after landing. Snow said he dreamed of teaching his daughter to fly one day but will likely never fly again.

The US Freedom Flyers are a group of volunteers within the transportation sector fighting to end vaccine mandates. They are warning the government that a tragedy could be on the horizon due to the FAA initially mandating vaccines under Biden’s guidance. The group would like all vaccinated pilots to receive medical clearance through EKGs and MRIs to rule out blood clotting issues. Once a pilot loses their FAA medical clearance, their career is over.

United Airlines even issued a “pilot incapacitation” manual and urged pilots and co-pilots to report incidents. As it stands, pilots are not permitted to fly for 48 hours after receiving the vaccine. However, the side effects could occur much later, and no one is seriously investigating why pilots are falling ill. “It’s as simple as standing up and saying NO! When we join together, we are an unstoppable force,” the US Freedom Flyers said.

Dr. Fauci was asked about the issue last October. “ I’m sure there is a very, very, very, very rare exception, but the long-term effects are really essentially nonexistent,” Fauci claimed. “Getting COVID is far, far worse than getting vaccinated for absolutely certain.”

Joe Biden Rails Against Inflation He Created


Posted originally on the conservative tree house on May 10, 2022 | Sundance

Even with dementia I doubt seriously Joe Biden believes the nonsense he read from his prepared script today.  Every economy policy the Biden administration has triggered, specifically including the Green New Deal energy policy, has caused massive inflation.

The national average price per gallon of gasoline was $2.33 in January 2021, according to the U.S. Energy Information Administration (EIA). It has increased nearly 84% when compared to the current national average price of $4.28 per gallon {link}.  Petroleum and refined gasoline costs are embedded in every aspect of the production economy.  Additionally, Biden’s restrictions, and later policies, on natural gas and coal have caused overall energy costs to skyrocket. Again, these are cornerstones of economic inflation.

During a ridiculously obtuse speech today [Full Speech Here], part of which is in the excerpt below, Biden claims there are only two sources of inflation: (1) the pandemic (covid-19); and (2) Russia’s invasion of Ukraine.  I often accuse democrats of pretending not to know things, however these false attributions are far beyond pretense, they are purposeful lies. WATCH:

Beyond the claims about inflation, a visible pile of bovine excrement is noted in the sentences around Ukraine grain supplies.  Notice there is no supply chain issue pushing thousands of tons of military hardware into Ukraine; however, Biden claims they cannot get grain supplies out of Ukraine.  He cannot even see the hypocrisy in his own script.

Sending more than $50 billion in U.S. taxpayer money to Ukraine while those same U.S. taxpayers are crushed under the weight of the inflation that type of spending creates, is beyond blood-boiling.  We are currently in an abusive relationship with our own government and Joe Biden is the cognitively challenged, disposable front man sent to the cameras to gaslight the American people.

Market from Volume to Targeted Boosts


TrialSite Staff by Staff at TrialSite | Quality Journalism May. 10, 2022, 9:00 a.m.

After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.

In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.

Vaccine producers such as Pfizer, Moderna, Johnson and Johnson (Janssen), AstraZeneca, and others understand that unless there are continued government mandates effectively priming the pump of demand, those individuals with a preference for COVID-19 immunization have already gone ahead with the procedure.

What’s left is a market for boosters and what could become some sort of annual shot available for targeted populations. Of course, in some markets, young children are still a target for COVID-19 vaccines.  Regardless, companies now operate in a quite different environment now, than they did in the period of late 2020 through 2021: a period driven by massive government spending, heavy industry influence on the regulatory process, risk-sharing, and the like to a more traditional competitive marketplace.

The Last Market: Young Children

While the children’s markets in places like America are still relevant, awaiting approval, what’s becoming apparent will be the emphasis on booster shots. In the world’s most lucrative drug market, America, Pfizer, and Moderna will more than likely persist as market leaders vying for the parental demands of children as public health agencies such as the CDC continue to emphasize that the risk-benefit analysis of the COVID-19 vaccine favor by a long-shot vaccination. The point of view is that there are no risk-free choices and that it’s better to be safe than sorry with the very youngest members of society. 

To date, the CDC recommends the Pfizer vaccine for both the 5-11 age and 12 to 17 cohort while not recommending Moderna. Under 4 is the last market segment the vaccine makers vie for, and if the FDA authorizes, then Pfizer would own that market. A potential battle emerges over this cohort (aged 4-11) as a growing movement concerned for the safety associated with the vaccines, especially the mRNA-based products, gains momentum to question the mass vaccination on this young population. Critics argue that the original premise for mandates and the like was to control community transmission.  Given substantial waning vaccine effectiveness combined with mutating variants, critics suggest the risks of serious infection and death are too low, and the safety issues are higher than the government is letting on. 

Demand for Vaccines Wane

But demand for vaccines is flat in much of the world. In America, there is little uptick in vaccination as the “fully vaccinated” defined as receiving the two jabs of either Pfizer-BioNTech, Moderna or one jab from Janssen equals 66.8% of the population while about 30.7% of the population opted for a booster dose.

Meanwhile, TrialSite, on several occasions, has chronicled a global glut of COVID-19 vaccines and therapeutics, especially in places like India, the world’s second-highest populated country. In places like Australia, where the death rate associated with COVID-19 has absolutely skyrocketed despite high immunization rates, the public health agencies and politicians continue to promote booster doses as the answer. TrialSite reported recently that Australian politicians in an election season essentially pretend that times are back to normal despite record numbers of cases, near-record hospitalizations, and double the deaths in the first months of 2022 than all of 2020 and 2021 combined.

Some Possible Explanations

Reuters’ Michael Erman and Manas Mishra write that vaccine producers such as Novavax and CureVac, the German mRNA-vaccine maker in partnership with GlaxoSmithKline, seek to target this booster market. Novavax still awaits FDA authorization despite the fact that much of the developed world, from Europe to Canada and Japan to the WHO, have authorized the use of the Novavax vaccine.

Meanwhile, the outlook for Janssen and AstraZeneca (Oxford) is that bright, report the Reuters journalists. According to Hartaj Singh, an analyst from Oppenheimer & Co., “It becomes a very competitive game with companies battling it out with pricing and for market share, even for vaccines that are considered to be the best, like Pfizer and Moderna.”

Interestingly, Pfizer’s CEO Albert Bourla went on the record in an interview recently that those adults that have opted to receive a COVID-19 vaccine are not likely to start accepting shots now in a recognition that the mega push for vaccine administration has come and gone.

Moderna has pegged the unfolding market as the annual shot market, targeting the following:

  • Adults 50 and above
  • People with comorbidities or other risks
  • High-risk occupations (e.g., healthcare, etc.)

According to the estimates of Stephane Bancel, Moderna’s CEO, this emerging annual shot market totals 1.7 billion, representing 21% of the global population. The mRNA-based vaccines are more expensive and cumbersome to distribute and store, hence a sizeable chunk of that estimated target may opt for other vaccines such as the two recently touted by vaccine insiders at WHO including a plant-based vaccine from Canada and one from China. 

More than likely Western Europe and America will represent central markets for sales for Pfizer and Moderna who will move toward more competitive, targeted responsive strategies as large government pre-purchases are probably going to be far less. Moreover, TrialSite suggests what were cozy relationships between industry and government agencies will become less so as the various governments’ responses to the pandemic will be a hot topic, especially in democracies in current election cycles.

Key Question: A flu shot model or something else?

The Reuters writers posed an important question in the recent piece: will the likes of Pfizer and Moderna starting this fall market a tailored, redesigned vaccine targeted relevant variants of concern (e.g., Omicron, BA.2, etc.)?

Both Moderna and Pfizer executives are on the record that they are developing Omicron-targeted vaccines.

This becomes an important topic as even the mainstream media starts to become slightly critical of the pandemic response, including mRNA-based vaccine makers that never modified the vaccine product once. The vaccine authorized and approved in the United States was developed based on the original Wuhan variant of SARS-CoV-2 which didn’t seem to make it in circulation to America nor most of the world.

Revenues Decline (but still unprecedented)

2023 sales numbers, while still staggering as compared to historical precedent in the pharmaceutical industry, are nonetheless, on the decline. Reuters reports $17 billion projected for Pfizer-BioNTech (down nearly half from $34 billion) and $10 billion for Moderna as compared to $23 billion in 2022. Sales will continue to drop because enormous fortunes were generated in the winner-take-all pandemic market.

TrialSite suggests the COVID-19 pandemic response must be seriously evaluated due to levels of bias, political interference, and potentially corruption at an unprecedented level. Should the political conditions change in the United States for example, leading to serious inquiries, the pandemic winners may incur unexpected costs.

After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.

In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response. TrialSite Staff by Staff at TrialSite | Quality Journalism

May. 10, 2022, 9:00 a.m.

After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.

In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.

Vaccine producers such as Pfizer, Moderna, Johnson and Johnson (Janssen), AstraZeneca, and others understand that unless there are continued government mandates effectively priming the pump of demand, those individuals with a preference for COVID-19 immunization have already gone ahead with the procedure.

What’s left is a market for boosters and what could become some sort of annual shot available for targeted populations. Of course, in some markets, young children are still a target for COVID-19 vaccines.  Regardless, companies now operate in a quite different environment now, than they did in the period of late 2020 through 2021: a period driven by massive government spending, heavy industry influence on the regulatory process, risk-sharing, and the like to a more traditional competitive marketplace.

The Last Market: Young Children

While the children’s markets in places like America are still relevant, awaiting approval, what’s becoming apparent will be the emphasis on booster shots. In the world’s most lucrative drug market, America, Pfizer, and Moderna will more than likely persist as market leaders vying for the parental demands of children as public health agencies such as the CDC continue to emphasize that the risk-benefit analysis of the COVID-19 vaccine favor by a long-shot vaccination. The point of view is that there are no risk-free choices and that it’s better to be safe than sorry with the very youngest members of society. 

To date, the CDC recommends the Pfizer vaccine for both the 5-11 age and 12 to 17 cohort while not recommending Moderna. Under 4 is the last market segment the vaccine makers vie for, and if the FDA authorizes, then Pfizer would own that market. A potential battle emerges over this cohort (aged 4-11) as a growing movement concerned for the safety associated with the vaccines, especially the mRNA-based products, gains momentum to question the mass vaccination on this young population. Critics argue that the original premise for mandates and the like was to control community transmission.  Given substantial waning vaccine effectiveness combined with mutating variants, critics suggest the risks of serious infection and death are too low, and the safety issues are higher than the government is letting on. 

Demand for Vaccines Wane

But demand for vaccines is flat in much of the world. In America, there is little uptick in vaccination as the “fully vaccinated” defined as receiving the two jabs of either Pfizer-BioNTech, Moderna or one jab from Janssen equals 66.8% of the population while about 30.7% of the population opted for a booster dose.

Meanwhile, TrialSite, on several occasions, has chronicled a global glut of COVID-19 vaccines and therapeutics, especially in places like India, the world’s second-highest populated country. In places like Australia, where the death rate associated with COVID-19 has absolutely skyrocketed despite high immunization rates, the public health agencies and politicians continue to promote booster doses as the answer. TrialSite reported recently that Australian politicians in an election season essentially pretend that times are back to normal despite record numbers of cases, near-record hospitalizations, and double the deaths in the first months of 2022 than all of 2020 and 2021 combined.

Some Possible Explanations

Reuters’ Michael Erman and Manas Mishra write that vaccine producers such as Novavax and CureVac, the German mRNA-vaccine maker in partnership with GlaxoSmithKline, seek to target this booster market. Novavax still awaits FDA authorization despite the fact that much of the developed world, from Europe to Canada and Japan to the WHO, have authorized the use of the Novavax vaccine.

Meanwhile, the outlook for Janssen and AstraZeneca (Oxford) is that bright, report the Reuters journalists. According to Hartaj Singh, an analyst from Oppenheimer & Co., “It becomes a very competitive game with companies battling it out with pricing and for market share, even for vaccines that are considered to be the best, like Pfizer and Moderna.”

Interestingly, Pfizer’s CEO Albert Bourla went on the record in an interview recently that those adults that have opted to receive a COVID-19 vaccine are not likely to start accepting shots now in a recognition that the mega push for vaccine administration has come and gone.

Moderna has pegged the unfolding market as the annual shot market, targeting the following:

  • Adults 50 and above
  • People with comorbidities or other risks
  • High-risk occupations (e.g., healthcare, etc.)

According to the estimates of Stephane Bancel, Moderna’s CEO, this emerging annual shot market totals 1.7 billion, representing 21% of the global population. The mRNA-based vaccines are more expensive and cumbersome to distribute and store, hence a sizeable chunk of that estimated target may opt for other vaccines such as the two recently touted by vaccine insiders at WHO including a plant-based vaccine from Canada and one from China. 

More than likely Western Europe and America will represent central markets for sales for Pfizer and Moderna who will move toward more competitive, targeted responsive strategies as large government pre-purchases are probably going to be far less. Moreover, TrialSite suggests what were cozy relationships between industry and government agencies will become less so as the various governments’ responses to the pandemic will be a hot topic, especially in democracies in current election cycles.

Key Question: A flu shot model or something else?

The Reuters writers posed an important question in the recent piece: will the likes of Pfizer and Moderna starting this fall market a tailored, redesigned vaccine targeted relevant variants of concern (e.g., Omicron, BA.2, etc.)?

Both Moderna and Pfizer executives are on the record that they are developing Omicron-targeted vaccines.

This becomes an important topic as even the mainstream media starts to become slightly critical of the pandemic response, including mRNA-based vaccine makers that never modified the vaccine product once. The vaccine authorized and approved in the United States was developed based on the original Wuhan variant of SARS-CoV-2 which didn’t seem to make it in circulation to America nor most of the world.

Revenues Decline (but still unprecedented)

2023 sales numbers, while still staggering as compared to historical precedent in the pharmaceutical industry, are nonetheless, on the decline. Reuters reports $17 billion projected for Pfizer-BioNTech (down nearly half from $34 billion) and $10 billion for Moderna as compared to $23 billion in 2022. Sales will continue to drop because enormous fortunes were generated in the winner-take-all pandemic market.

TrialSite suggests the COVID-19 pandemic response must be seriously evaluated due to levels of bias, political interference, and potentially corruption at an unprecedented level. Should the political conditions change in the United States for example, leading to serious inquiries, the pandemic winners may incur unexpected costs.

After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.

In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.

Johnson & Johnson Vaccine Recall


Armstrong Economics Blog/Vaccine Re-Posted May 9, 2022 by Martin Armstrong

The FDA has finally admitted what we knew all along – the vaccine is not safe. The FDA said it is limiting the availability of Johnson & Johnson’s COVID-19 vaccine as it does indeed cause blood clots. The agency also noted that the vaccine presents a risk of thrombosis with thrombocytopenia syndrome.

The health agencies are still pushing the vaccines from Moderna and Pfizer. How are they any different? The US government has a long history of punishing Johnson & Johnson for their illegal activities, from asbestos-laced baby powder to cancerogenic sunscreen. Yet, all pharmaceutical manufacturers are exempt from penalty for the COVID-19 vaccine, citing a national emergency.

FDA’s vaccine chief Dr. Peter Marks said that the risk of death is still better than not getting the jab and said Johnson & Johnson’s version may be used as a last resort. Johnson & Johnson was hoping to rake in $3.5 billion this year from the vaccine alone. All of this comes down to money and control. The government and businesses forced mandates with complete disregard for public health. The talking heads gaslit the world for years into believing anyone who questioned the vaccine was a conspiracy theory lunatic, unfit for society.

They have known the truth all along. The Johnson & Johnson vaccine came into question in April 2021. Here is Fauci maintaining that the Johnson & Johnson vaccine was “safe and effective” despite knowing it could be deadly:

The Left Turns on Newsom


Armsrong Economics Blog/USA Current Events Re-Posted May 9, 2022 by Martin Armstrong

Gavin Newsom’s goal to become the most woke governor in America has backfired as all words are now deemed offensive as well as hand gestures. The internet is ablaze with angry voters who want Gavin out of office for his transphobic comment. His crime? He stated that men cannot get pregnant“If men could get pregnant, this wouldn’t even be a conversation,” the non-inclusive and intolerant governor stated in support of Roe v. Wade. Blaming cis-gendered males is OK and encouraged, but stating that they are unable to carry a child is not.

Newsom carelessly failed to mention the other 71 genders who can also give birth. Schools in the US will begin teaching children all 72 genders and will allow them to choose which ones they like the best. Biden has removed the word “mother” from all government documents in favor of “birthing person.” How will they explain to children that a uterus is necessary to produce life?

The Ministry of Truth will certainly clarify the situation for us. Gavin Newsom said abortion “will be the defining issue of the 2022 election,” which is exactly why the Supreme Court document was leaked. Newsom said he will fight to protect “women” – oh no, there he goes again. If his campaign is built on angering the left, he better tread lightly.

Don’t Divert Your Attention to Roe v. Wade


Armstrong Economics Blog/USA Current Events Re-Posted May 6, 2022 by Martin Armstrong

A coming Supreme Court ruling to overturn Roe v. Wade was secretly “leaked.” Uncoincidentally, the news came right before the 2022 US midterm elections. Everyone is understandably up in arms after Biden formed a Disinformation Governance Board to become the ultimate authority for what we may believe is true. Most Americans want Biden out of office, with only 37% saying he should run for re-election.

The fake plight to save the people of Ukraine was not enough to garner Democratic support. The virtue-signaling appealed to the left at first, until Biden handed Ukraine billions of dollars and dismissed his campaign promise to forgive student debt. The COVID power grab has loosened from Biden’s grip, and his approval numbers have been steadily declining.

Abortion has been a hot topic since Roe v. Wade permitted the practice in 1973. The same people who are shouting, “MY BODY, MY CHOICE!” did not feel that way when the government wanted to mandate experimental vaccines. They were OK with countless people losing their jobs and lives because the government knew what was best for our health, and we had a moral obligation to obey. They claim Roe v. Wade protects women but are attempting to eliminate women from our society.

The latest Supreme Court Justice Kentanji Jackson said she could not define a “woman” as she is not a biologist. Biden actually banned the word “mothers” as femininity is offensive to the far left. Instead, we are supposed to call them “birthing people” since the woke community maintains that men can give birth. Apple even added pregnant men emojis to its platform.

Not to be outdone, the US is #1 for infant mortality among developed nations. Do you know the leading cause of death for “birthing people” in the US? HOMICIDEMore women die in this country from homicide than from pregnancy or birthing complications. Black women in particular are three times as likely to die from homicide while pregnant. Men are almost always the culprit.

Yet, no one sees gender or these very alarming issues. Women are no longer protected in this country; Roe v. Wade is not the issue. How can we protect women when we deny their existence?

Biden’s America, Supreme Court Justices Threatened by Democrat Activists, Fences Installed to Prevent Insurrection, White House Silent


Posted originally on the conservative tree house on May 5, 2022 | Sundance

This is the state of our union.  These are the real Domestic Violent Extremists (DVE’s).

Democrat activists have listed the names and home addresses of conservative Supreme Court justices in an effort to organize violence against the court.  A taller perimeter fence was installed around the Supreme Court building last night to stop any violent efforts by democrat activists, and personal security measures have been increased for the justices.

(Daily Mail) – An activist group called ‘Ruth Sent Us’ has published the supposed addresses of Justices Samuel Alito, Clarence Thmas, Neil Gorsuch, Brett Kavanaugh, Amy Coney Barrett and Chief Justice John Roberts and are planning a ‘walk-by’ of their homes next Wednesday, May 11.

‘Our 6-3 extremist Supreme Court routinely issues rulings that hurt women, racial minorities, LGBTQ+ and immigrant rights,’ the group’s website reads. ‘We must rise up to force accountability using a diversity of tactics.’ (read more)

Unfortunately, and in keeping with all prior support precedent for Occupy Wall Street, Black Lives Matter, Antifa and other violent groups, the installed president and radical administration officials have aligned themselves with the violent confrontation.  The White House has refused to speak out against the intimidation effort and/or condemn the violence.

This is the state of our union with Democrats attacking the institutions of government.

The security officials for Justice Alito cancelled plans for him to participate in the 5th Circuit Court of Appeals judicial conference starting on Thursday, as the associate justice is tasked with reviewing emergency appeals from the 5th Circuit. It is unclear if Justice Roberts and Justice Thomas, who were slated to get remarks at a similar conference for the 11th Circuit on Thursday and Friday, will still appear.

Rand Paul Questions DHS Secretary About Disinformation, Mayorkas Accidentally Gives Game Away “Should I Sit Back and Take That?”


Posted originally on the conservative house on May 4, 2022 | Sundance

Kentucky Senator Rand Paul questioned DHS Secretary Mayorkas about what constitutes disinformation and what will the DHS Disinformation Bureau do about it?  {Direct Rumble Link}

After multiple back and forth dodges by the DHS Secretary, at 06:40 Mayorkas slips a little and gives an example using the COVID vaccination program. After giving the example of a hypothetical claim of the vaccine containing fentanyl, Mayorkas asks “should I sit back and accept that,” meaning do nothing about it.

Right there Mayorkas gives away the intent and purpose of the Ministry of Truth.  Identify disinformation, then communicate with the networked partnership of social media companies, and then target whoever made the claim.  The government then controls the speech.  The government then becomes the arbiter of what is true and/or false.  The problem as Rand Paul is drilling down, is that ultimately government will approve speech.  WATCH:

There is no such thing as “disinformation.”  There is information the government approves of, and information that is averse to the interest of government.  That’s the bottom line and the end of this regulatory slippery slope discussion.

Example: Ask the DHS Disinformation Governance Board if a fetus is a baby human?